32 results
8-K
EX-99.1
ATHA
Athira Pharma Inc
15 May 24
Athira Pharma Reports First Quarter 2024 Financial Results and Pipeline and Business Updates
4:10pm
in a first-in-human study in second quarter of 2024
Strong balance sheet to support innovative pipeline through key clinical inflection points
8-K
EX-99.1
ATHA
Athira Pharma Inc
22 Feb 24
Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates
4:10pm
to support innovative pipeline through key inflection points
BOTHELL, Wash., February 22, 2024 – Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage
8-K
EX-99.1
ATHA
Athira Pharma Inc
8 Jan 24
Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update
7:11am
the advancement of the Company’s innovative pipeline through key inflection points.
About Athira Pharma, Inc.
Athira Pharma, Inc., headquartered in the Seattle
8-K
EX-99.1
tjsyk
9 Nov 23
Athira Pharma Reports Third Quarter 2023 Financial Results and Pipeline and Business Updates
4:10pm
8-K
EX-99.1
9nxge7qy jyb
10 Aug 23
Athira Pharma Reports Second Quarter 2023 Financial Results and Pipeline and Business Updates
4:10pm
8-K
EX-99.1
vdvmecp3jqla5hn
11 May 23
Athira Pharma Reports First Quarter 2023 Financial Results
4:11pm
DFAN14A
EX-99.1
cydlsm8j0r4
13 Apr 22
Additional proxy materials by non-management
5:29pm
8-K
EX-99.1
xouy7e1ym
24 Mar 22
Athira Pharma Reports Full Year 2021 Financial Results and Provides Clinical Update
4:11pm
8-K
EX-99.1
svjz6j 77
21 Mar 22
Athira Pharma Announces Appointment of Dr. Michael A. Panzara to its Board of Directors
7:21am
8-K
EX-99.1
1pu7rgo
31 Jan 22
Athira Pharma Announces Appointment of Grant Pickering to its Board of Directors
4:15pm
S-3
ydi8m0y1208uacqtxvd
15 Nov 21
Shelf registration
4:06pm